Vertex Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
22.01.26
/
50%
€391.10
Target price
22.01.27
€467.05
Performance (%)
0.37%
Price
10:21
€392.55
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Vertex Pharmaceuticals Inc. is nearly unchanged. This prediction currently runs until 22.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | 0.37% |
| iShares Core DAX® | -1.764% |
| iShares Nasdaq 100 | -1.632% |
| iShares Nikkei 225® | -2.451% |
| iShares S&P 500 | -2.252% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat